{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:12:13Z","timestamp":1792512733913,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Robot-assisted radical prostatectomy (RARP) has rapidly expanded and become the leading surgical approach for prostate cancer in Japan. However, it remains unclear whether the concurrent increase in radical prostatectomy reflects population aging, increased diagnostic activity, or shifts in treatment selection after diagnosis. We performed a nationwide descriptive time-series analysis using publicly available Japanese administrative claims, cancer registry data, population statistics, and hospital function reports. We identified prostate cancer surgeries, laboratory testing, and prostate biopsies through reimbursement codes and analyzed them as annual claim counts. Surgical procedures were categorized as open, laparoscopic, minimally invasive endoscopic, or RARP. Trends from 2016 to 2024 were evaluated, and age-specific metrics for men aged 75\u201379, 80\u201384, and\u2009\u2265\u200985 years were referenced to 2018. Prostate cancer surgeries rose from 21,988 in 2016 to 29,548 in 2024. RARP procedures increased from 13,415 to 27,911, comprising 94.5% of all surgeries in 2024. The share of surgeries in men aged\u2009\u2265\u200975 years grew from 12.3% to 30.5% and among men aged\u2009\u2265\u200980 years, it rose from 0.9% to 4.7%. For men aged 80\u201384 years, the 2024 surgery index reached 463.0, surpassing the indices for population size, incidence, mortality, prostate-specific antigen testing, and biopsy. Radical prostatectomy increased disproportionately among older men in Japan, particularly those aged 80\u201384 years, predominantly through the expansion of RARP. These population-level trends highlight the need for individualized patient selection based on frailty, life expectancy, tumor risk, and expected treatment benefit to mitigate potential overtreatment in older men.<\/jats:p>","DOI":"10.1007\/s11701-026-03817-4","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:10:19Z","timestamp":1786939819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disproportionate expansion of radical prostatectomy among older men in Japan in the robotic surgery era: a nationwide descriptive time series analysis"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-6218","authenticated-orcid":false,"given":"Tomohiko","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"2","key":"3817_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"issue":"16","key":"3817_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB (2025) Prostate cancer: a review. JAMA 333(16):1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"JAMA"},{"issue":"10","key":"3817_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/jjco\/hyu104","volume":"44","author":"M Onozawa","year":"2014","unstructured":"Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T et al (2014) Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. Jpn J Clin Oncol 44(10):969\u2013981. https:\/\/doi.org\/10.1093\/jjco\/hyu104","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"3817_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/jjco\/hyae079","volume":"54","author":"T Kawai","year":"2024","unstructured":"Kawai T, Onozawa M, Taguchi S, Shiota M, Sakamoto S, Yamamoto Y et al (2024) Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study. Jpn J Clin Oncol 54(9):1045\u20131051. https:\/\/doi.org\/10.1093\/jjco\/hyae079","journal-title":"Jpn J Clin Oncol"},{"key":"3817_CR5","unstructured":"Statistics Bureau of Japan.: e-Stat: Portal Site of Official Statistics of Japan. https:\/\/www.e-stat.go.jp\/en\/ Accessed 17 Jun 2026."},{"key":"3817_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-46171-z","author":"N Kawamura","year":"2026","unstructured":"Kawamura N, Nakayama M, Inagaki Y, Tsutahara K, Hatano K, Nakayama J et al (2026) Age-stratified trajectories of patient-reported outcomes and perioperative safety after robot-assisted radical prostatectomy: a prospective multicenter cohort study. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-026-46171-z","journal-title":"Sci Rep"},{"issue":"2","key":"3817_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10147-024-02660-7","volume":"30","author":"S Koterazawa","year":"2025","unstructured":"Koterazawa S, Kubota M, Sumiyoshi T, Saito R, Takaoka N, Hattori Y et al (2025) Effects of aging on complications following robot-assisted radical prostatectomy. Int J Clin Oncol 30(2):340\u2013350. https:\/\/doi.org\/10.1007\/s10147-024-02660-7","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"3817_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-025-02945-7","volume":"20","author":"L Flegar","year":"2026","unstructured":"Flegar L, Shi W, Pan HYC, Santiago MA, Thomas BC, Lawrentschuk N et al (2026) Robotic-assisted radical prostatectomy in patients 80+\u2009years: a multi-centre experience. J Robot Surg 20(1):142. https:\/\/doi.org\/10.1007\/s11701-025-02945-7","journal-title":"J Robot Surg"},{"issue":"2","key":"3817_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/pros.70063","volume":"86","author":"V Yu","year":"2026","unstructured":"Yu V, Treacy PJ, Thanigasalam R, Ahmadi N, Doeuk N, Woo H et al (2026) Robotic-assisted radical prostatectomy in the elderly patient-a study of functional, surgical, and oncological outcomes in an Australian cohort. Prostate 86(2):158\u2013166. https:\/\/doi.org\/10.1002\/pros.70063","journal-title":"Prostate"},{"key":"3817_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-026-02102-8","author":"K Fransis","year":"2026","unstructured":"Fransis K, Bouziotis J, Tappero S, De Wachter S, Dirix P, De Win G (2026) Outcomes of Retzius-sparing robot-assisted radical prostatectomy in men aged\u2009\u2265\u200975 years. BMC Urol. https:\/\/doi.org\/10.1186\/s12894-026-02102-8","journal-title":"BMC Urol"},{"issue":"3","key":"3817_CR11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijrobp.2023.09.018","volume":"118","author":"H Shaheen","year":"2024","unstructured":"Shaheen H, Salans MA, Mohamad O, Coleman PW, Ahmed S, Roach M 3rd (2024) Age 70 +\/- 5 years and cancer-specific outcomes after treatment of localized prostate cancer: a systematic review. Int J Radiat Oncol Biol Phys 118(3):672\u2013681. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3817_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-026-05056-w","author":"Q Chen","year":"2026","unstructured":"Chen Q, Wu J, Cai Q (2026) Impact of frailty on overall survival and complications in patients with prostate cancer: a systematic review and meta-analysis. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-026-05056-w","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"3817_CR13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/cas.13293","volume":"108","author":"H Masaoka","year":"2017","unstructured":"Masaoka H, Ito H, Yokomizo A, Eto M, Matsuo K (2017) Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan. Cancer Sci 108(8):1673\u20131680. https:\/\/doi.org\/10.1111\/cas.13293","journal-title":"Cancer Sci"},{"issue":"3","key":"3817_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/iju.15102","volume":"30","author":"T Kato","year":"2023","unstructured":"Kato T, Tohi Y, Honda T, Matsuda I, Osaki Y, Naito H et al (2023) A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer. Int J Urol 30(3):289\u2013297. https:\/\/doi.org\/10.1111\/iju.15102","journal-title":"Int J Urol"},{"issue":"1","key":"3817_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.35772\/ghm.2022.01065","volume":"5","author":"M Nakamura","year":"2023","unstructured":"Nakamura M, Suzuki M, Izumi T, Tsuru I, Muraki Y, Kume H (2023) Trends in surgical treatment for prostate cancer: analysis of National Database Open Data in Japan. Glob Health Med 5(1):62\u201363. https:\/\/doi.org\/10.35772\/ghm.2022.01065","journal-title":"Glob Health Med"},{"key":"3817_CR16","unstructured":"Ministry of Health, Labour and Welfare: Annual Report on Hospital Bed Functions (Public Data). https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000055891.html Accessed 17 Jun 2026."},{"key":"3817_CR17","unstructured":"Ministry of Health, Labour and Welfare: NDB Open Data. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html Accessed 17 Jun 2026."},{"key":"3817_CR18","unstructured":"National Cancer Center Japan: National Cancer Registry. https:\/\/ganjoho.jp\/med_pro\/cancer_control\/can_reg\/index.html Accessed 17 Jun 2026."},{"key":"3817_CR19","unstructured":"Wennberg JE. The Dartmouth Atlas of Health Care. Supply-Sensitive Care: A Dartmouth Atlas Project Topic Brief. Lebanon (NH): The Dartmouth Institute for Health Policy and Clinical"},{"issue":"2","key":"3817_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11606-014-2980-0","volume":"30","author":"KR Riggs","year":"2015","unstructured":"Riggs KR, Ubel PA (2015) The role of professional societies in limiting indication creep. J Gen Intern Med 30(2):249\u2013252. https:\/\/doi.org\/10.1007\/s11606-014-2980-0","journal-title":"J Gen Intern Med"},{"issue":"1","key":"3817_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.35772\/ghm.2026.01011","volume":"8","author":"M Uenishi","year":"2026","unstructured":"Uenishi M, Song P, Karako T (2026) Japan\u2019s high-quality healthcare system despite physician shortages: exploring the paradox and pathways toward sustainable healthcare. Glob Health Med 8(1):8\u201312. https:\/\/doi.org\/10.35772\/ghm.2026.01011","journal-title":"Glob Health Med"},{"issue":"3","key":"3817_CR22","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1245\/s10434-025-18740-5","volume":"33","author":"M Baunacke","year":"2026","unstructured":"Baunacke M, Huber J, Haak L, Thomas C, Groeben C (2026) Increasing age at radical prostatectomy: a total population analysis in Germany from 2006 to 2022. Ann Surg Oncol 33(3):2783\u20132790. https:\/\/doi.org\/10.1245\/s10434-025-18740-5","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3817_CR23","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1245\/s10434-025-18827-z","volume":"33","author":"M Baunacke","year":"2026","unstructured":"Baunacke M, Huber J, Haak L, Thomas C, Groeben C (2026) ASO author reflections: shifting age demographics in prostate cancer surgery: insights from 17 years of German data. Ann Surg Oncol 33(3):2809\u20132810. https:\/\/doi.org\/10.1245\/s10434-025-18827-z","journal-title":"Ann Surg Oncol"},{"key":"3817_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205061","author":"Y Yamada","year":"2022","unstructured":"Yamada Y, Taguchi S, Kume H (2022) Surgical tolerability and frailty in elderly patients undergoing robot-assisted radical prostatectomy: a narrative review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14205061","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3817_CR25","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s11701-023-01714-8","volume":"17","author":"J Wang","year":"2023","unstructured":"Wang J, Hu K, Wang Y, Wu Y, Bao E, Wang J et al (2023) Robot-assisted versus open radical prostatectomy: a systematic review and meta-analysis of prospective studies. J Robot Surg 17(6):2617\u20132631. https:\/\/doi.org\/10.1007\/s11701-023-01714-8","journal-title":"J Robot Surg"},{"issue":"1","key":"3817_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/ju.0000000000003967","volume":"212","author":"WC Nahas","year":"2024","unstructured":"Nahas WC, Rodrigues GJ, Rodrigues Gon\u00e7alves FA, Sawczyn GV, Barros GG, Cardili L et al (2024) Perioperative, oncological, and functional outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy: a randomized clinical trial. J Urol 212(1):32\u201340. https:\/\/doi.org\/10.1097\/ju.0000000000003967","journal-title":"J Urol"},{"key":"3817_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-026-05182-5","author":"CV Suartz","year":"2026","unstructured":"Suartz CV, Costa MSS, Matalani CFA, da Rocha MR, Micheleto JPC, Furlam PL et al (2026) Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-026-05182-5","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"3817_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/iju.70567","volume":"33","author":"S Sakamoto","year":"2026","unstructured":"Sakamoto S, Yamamoto K, Yamamoto H, Hatakeyama S, Mizuno R, Yasui T et al (2026) A nationwide descriptive analysis of real-world outcomes after radical prostatectomy in Japan using the National Clinical Database. Int J Urol 33(7):e70567. https:\/\/doi.org\/10.1111\/iju.70567","journal-title":"Int J Urol"},{"issue":"3","key":"3817_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/rcs.70084","volume":"21","author":"K Obayashi","year":"2025","unstructured":"Obayashi K, Akatsuka J, Nishino T, Takadate M, Hasegawa H, Mikami H et al (2025) Clinical and economic assessment of robot-assisted radical prostatectomy with the Hinotori Surgical System: insights from a Japanese single-centre study. Int J Med Robot 21(3):e70084. https:\/\/doi.org\/10.1002\/rcs.70084","journal-title":"Int J Med Robot"},{"key":"3817_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104220","volume":"91","author":"H Murayama","year":"2020","unstructured":"Murayama H, Kobayashi E, Okamoto S, Fukaya T, Ishizaki T, Liang J et al (2020) National prevalence of frailty in the older Japanese population: findings from a nationally representative survey. Arch Gerontol Geriatr 91:104220. https:\/\/doi.org\/10.1016\/j.archger.2020.104220","journal-title":"Arch Gerontol Geriatr"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03817-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:10:21Z","timestamp":1786939821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03817-4","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable because this study used only publicly available, aggregated, and anonymized data.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The opinions in this article belong to the authors and may not represent the official stance or policies of the Pharmaceuticals and Medical Devices Agency.","order":4,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used only publicly available, aggregated, and anonymized data, with no involvement of individual human participants. In accordance with Japanese ethical guidelines, ethics approval was not required.","order":5,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"844"}}